Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer

To evaluate the outcomes of total eradication therapy (TET), designed to eradicate all sites of visible cancer and micrometastases, in men with newly diagnosed oligometastatic prostate cancer (OMPCa). Men with ≤ 5 sites of metastases were enrolled in a prospective registry study, underwent neoadjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes, D. K., Rowe, S. P., Schaeffer, E. M., Allaf, M. E., Ross, A. E., Pavlovich, C. P., Deville, C., Tran, P. T., Pienta, K. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286864/
https://www.ncbi.nlm.nih.gov/pubmed/32524295
http://dx.doi.org/10.1007/s12032-020-01385-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286864/
https://www.ncbi.nlm.nih.gov/pubmed/32524295
http://dx.doi.org/10.1007/s12032-020-01385-7

Ejemplares similares